Css LLC Horizon Therapeutics Public LTD CO Call Options Transaction History

Css LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	SELL	$98.98 - $115.74 $2.21 Million - $2.58 Million	-22,300 Reduced 62.64%	13,300 $1.54 Million
Q2 2023 Aug 14, 2023	BUY	$96.34 - $112.38 $2.72 Million - $3.17 Million	28,200 Added 381.08%	35,600 $3.66 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $386,352 - $408,600	3,600 Added 94.74%	7,400 $807,000
Q4 2022 Feb 14, 2023	BUY	$62.39 - $113.8 $237,082 - $432,440	3,800 New	3,800 $432,000
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $2.51 Million - $3.34 Million	-35,000 Closed	0 $0

Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $1.68 Million - $2.11 Million	25,000 Added 250.0%	35,000 $2.56 Million
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $927,140 - $1.75 Million	-30,700 Reduced 75.43%	10,000 $556,000
Q3 2019 Nov 14, 2019	BUY	$23.0 - $27.97 $648,600 - $788,754	28,200 Added 225.6%	40,700 $1.11 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $285,125 - $356,000	12,500 New	12,500 $301,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Css LLC, based on Form 13F filings with the SEC.

Stay updated on Css LLC with notifications on news.